Heart Valve Disease Clinical Trial
Official title:
European Clinical Study for the Application of Regenerative Heart Valves - ESPOIR
This is a prospective, non-randomized, single-arm, multicentre surveillance study to be conducted in Europe. The Surveillance is designed as a study, where - ESPOIR pulmonary valve (PV) is prescribed in the usual manner in accordance with the terms of the approval. - The assignment of the patient to a particular therapeutic strategy is not decided in advance by this Surveillance Protocol but falls within current practice and the prescription of ESPOIR PV is clearly separated from the decision to include the patient in the Surveillance. - No additional diagnostic or monitoring procedures shall be applied to the patients - and epidemiological methods shall be used for the analysis of collected data. Evaluation of decellularized human heart valves for pulmonary heart valve replacement in comparison to current valve substitutes. Safety endpoints include cardiovascular adverse events, time to re-operation, re-intervention and explantation. Efficacy endpoints include freedom from valve dysfunction and hemodynamic performance.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Completed |
NCT02527629 -
Aortic Replacement Using Individualised Regenerative Allografts - ARISE (the "Surveillance")
|
||
Completed |
NCT01178710 -
Effect of Simvastatin on Cardiac Function
|
N/A | |
Completed |
NCT01426776 -
Effect of Heart Valve Replacement on Cheyne-Stokes Respiration
|
N/A | |
Completed |
NCT00581399 -
A Randomized Multicenter Clinical Study On the High Vacuum Body Cavity Drainage System Following Open Heart Surgery
|
Phase 2 | |
Withdrawn |
NCT00187304 -
ACTION - Anticoagulation Treatment Influence on Post-operative Patients
|
Phase 4 | |
Terminated |
NCT00700947 -
Using Beta Blockers to Treat Mitral Regurgitation
|
Phase 1 | |
Recruiting |
NCT02574650 -
Early Feasibility of the Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) Also Known as TriAlign™.
|
N/A | |
Recruiting |
NCT02650388 -
Frailty and Cognitive Function Assessment of TAVI Patients
|
Phase 4 | |
Completed |
NCT01996657 -
D-dimer and Oral Anticoagulation Therapy in Patients With Mechanical Valve Replacement
|
N/A | |
Terminated |
NCT00598936 -
A Prospective Study With a New Device for the Monitoring of Cerebral Oxygenation on Cardiac Surgery Patients
|
Phase 1 | |
Terminated |
NCT01812174 -
On-X Heart Valve - 17mm Aortic and 23mm Mitral
|
N/A | |
Recruiting |
NCT03225612 -
Safety and Performance of the Trialign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS)
|
N/A | |
Completed |
NCT01384643 -
Effect of Propofol on Renal Injury in Patients Undergoing Valvular Heart Surgery
|
Phase 4 | |
Completed |
NCT01558765 -
CopenHeartVR - Integrated Rehabilitation of Patients After Heart Valve Surgery
|
Phase 2 | |
Active, not recruiting |
NCT00291525 -
Randomized On-X Anticoagulation Trial
|
N/A | |
Completed |
NCT02867930 -
Comparative Effects of Dexmedetomidine and Ketofol for Sedation in Patients Undergoing Trans-esophageal Echocardiography
|
Phase 4 | |
Recruiting |
NCT02478008 -
A Clinical Study of the CardiAQ™ TMVI System (Transapical DS)
|
N/A | |
Completed |
NCT02790008 -
Magnetic Resonance Imaging and Fibrosis
|
||
Completed |
NCT02587039 -
An Intervention to Reduce Delirium After Cardiac Surgery
|
N/A |